RBI Call/Frequentis 23-25/ AT0000A375W2 /
13/05/2024 9:15:01 | Diferencia-0.003 | Bid17:29:55 | Ask17:29:55 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.144EUR | -2.04% | - Volumen de oferta: - |
- Tamaño/ Volumen/ Formato de Ask: - |
FREQUENTIS AG | 31.00 EUR | 21/03/2025 | Call |
GlobeNewswire
22:58
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
22:47
Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock
GlobeNewswire
22:45
Harvard Apparatus Regenerative Technology Reports First Quarter 2024 Financial Results and Recent Bu...
GlobeNewswire
22:45
Ikena Oncology Reports First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire
22:44
Chocxo Dark Milk Chocolate Snaps Named a Winner in Good Housekeeping’s 2024 Best Snack Awards
GlobeNewswire
22:42
Jamf Announces Launch of Secondary Offering of Common Stock by Selling Stockholders and Related Comm...
GlobeNewswire
22:36
Zapata Computing Holdings Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
22:33
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against FAT Brands Inc...
GlobeNewswire
22:30
Farmers & Merchants Bancorp (FMCB) ranked #6 on Forbes Magazine’s List of “America’s Best Banks” for...
GlobeNewswire
22:30
Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference
GlobeNewswire
22:30
Cartesian Therapeutics to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conferen...
GlobeNewswire
22:30
STRATA Skin Sciences to Participate in the Benchmark Healthcare House Call Virtual 1x1 Investor Conf...
GlobeNewswire
22:30
Aerovate Therapeutics Announces First Quarter Financial Results and Business Highlights
GlobeNewswire
22:30
Tonix Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Highlights
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página